LBPH — Longboard Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- $1.05bn
- $729.88m
- 36
- 30
- 92
- 51
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 55.3 | 107 | 67.6 | 48.5 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 55.4 | 108 | 69.8 | 50.2 |
Net Property, Plant And Equipment | — | 0.535 | 0.745 | 0.476 |
Other Long Term Assets | ||||
Total Assets | 56.2 | 109 | 70.6 | 50.7 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Current Liabilities | 3.13 | 5.44 | 8.76 | 9.77 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 3.13 | 5.63 | 9.15 | 9.77 |
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 53.1 | 103 | 61.5 | 40.9 |
Total Liabilities & Shareholders' Equity | 56.2 | 109 | 70.6 | 50.7 |
Total Common Shares Outstanding |